Melanocyte protein Pmel 17 precursor (40-57)

Melanocyte protein Pmel 17 precursor (40-57) is a synthetic peptide fragment derived from the Pmel 17 glycoprotein, also known as gp100 or silver locus protein. This protein plays a pivotal role in the biogenesis of melanosomes, the specialized organelles responsible for melanin synthesis and storage in melanocytes. The (40-57) sequence corresponds to a defined region within the precursor molecule, making it a valuable tool for dissecting the structural and functional aspects of Pmel 17 in pigment cell biology. Its biochemical properties and sequence specificity provide a foundation for diverse research applications in cellular, molecular, and immunological studies related to pigmentation and melanocyte function.

Peptide mapping and epitope characterization: As a defined peptide segment, the 40-57 fragment serves as a critical reagent for mapping functional domains within the Pmel 17 protein. Researchers utilize this peptide to identify and characterize epitopes recognized by antibodies or T cells, supporting investigations into immune recognition of melanocyte antigens. Such studies are fundamental for elucidating the molecular determinants of antigenicity in pigment cell biology and can inform the design of immunological assays targeting melanosomal proteins.

Antibody validation and assay development: The synthetic peptide is frequently employed as a positive control or immunogen in the generation and validation of monoclonal and polyclonal antibodies specific to Pmel 17. By providing a well-defined antigenic sequence, the 40-57 fragment enables rigorous testing of antibody specificity and cross-reactivity in immunoblotting, immunohistochemistry, and ELISA platforms. This application streamlines the development of reliable tools for detecting and quantifying Pmel 17 expression in various cell and tissue samples.

Melanosome biogenesis research: The peptide fragment is instrumental in studies aimed at unraveling the molecular mechanisms underlying melanosome formation and maturation. By mimicking a portion of the native Pmel 17 precursor, it facilitates in vitro experiments that probe the interactions, processing, and assembly of melanosomal components. These investigations are essential for advancing the understanding of organelle biogenesis and the regulation of pigmentation at the cellular level.

Peptide-based functional assays: In functional studies, the 40-57 peptide is utilized to assess the biological activity of Pmel 17-derived sequences in cell culture models. Researchers may introduce the peptide to explore its influence on melanocyte signaling pathways, protein-protein interactions, or melanin synthesis processes. Such applications provide mechanistic insights into how discrete regions of Pmel 17 contribute to pigment cell physiology and organelle dynamics.

Immunological model systems: The defined nature of the peptide enables its use in constructing model systems for studying antigen processing and presentation by antigen-presenting cells. By incorporating the 40-57 sequence into experimental protocols, investigators can evaluate how peptide fragments derived from melanosomal proteins are processed and displayed by major histocompatibility complex (MHC) molecules. These studies are particularly relevant for understanding immune surveillance of pigment cells and the broader context of autoimmunity or immune tolerance in the skin.

1. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis